Transplant Surgery, University of Pennsylvania

Valeria Mas, PhD, MSc, FAST Joseph and Corinne Schwartz Endowed Professor Surgical Sciences Research in Transplantation, Professor of Surgery, Chief Surgical Science Division, School of Medicine, Department of Surgery, University of Maryland. Dr. Mas is the former Director and founder of the Transplant Research Institute, which is part of the Methodist University Transplant Institute associated with University of Tennessee Health Science Center.

Dr. Juan G. Abraldes is a Transplant Hepatologist, Professor and Director of the Liver Unit at the University of Alberta.

He did his MD at the University of Santiago de Compostela, Spain, and got his GI and hepatology training in Barcelona. He did a postdoctoral training at Yale University (2003–2004).

Dr. Thomas Reiberger is a Professor of Gastroenterology and Hepatology at the Medical University of Vienna and holds medical boards for Internal Medicine, Gastroenterology/Hepatology and ICU. He leads the advanced chronic liver disease (ACLD) program at the Vienna General Hospital, including outpatient clinics for patients with liver cirrhosis, portal hypertension, and for pre-post liver transplantation care. As physician scientist he performs invasive transjugular procedures, endoscopic hepatobiliary interventions and engages in intensive care management of GI/Liver patients.

Jordan Sack is a transplant hepatologist at Mass General Brigham. His research focus is in Fontan associated liver disease, cirrhosis, and portal hypertension.

I'm Vik Meadows, PhD, a postdoctoral fellow at the University of Pittsburgh researching the role of bile duct integrity in hepatocyte reprogramming and gut-liver axis homeostasis under the mentorship of Dr. Satdarshan 'Paul' Monga.

Neil Henderson is an academic hepatologist and Chair of Tissue Repair and Regeneration at the University of Edinburgh. Neil's group leverages cutting-edge approaches including the rapidly evolving field of single cell and spatial genomics to develop precision therapies for patients with liver fibrosis.

Anand Mehta, D.Phil. is the Senior Associate Dean for Research and SmartState Endowed Chair in Proteomic Biomarkers and Professor, Department of Cell and Molecular Pharmacology at the Medical University of South Carolina. Dr. Mehta received his graduate degree in Biochemistry from the University of Oxford under the mentorship of Professor Raymond Dwek and Nobel Laureate Baruch Blumberg. As a student, he worked on the role of N-linked glycosylation in the assembly and secretion of hepatitis B virus. Currently, Dr.

I am a gastroenterologist and hepatologist interested in using genomic methods to better understand disease mechanisms, especially in MASLD, liver cirrhosis and HCC.

Dr. Raeman is an Associate Professor in the Department of Pharmacology and Chemical Biology at the University of Pittsburgh and a core member of Pittsburgh Liver Research Center. Dr. Raeman earned his MS from Clemson University, PhD from the University of Georgia and completed his postdoctoral training at Emory University School of Medicine. Dr. Raeman specializes in delineating the cellular and molecular mechanisms of chronic liver diseases, specifically focusing on the role of gut-liver-immune axis in chronic liver disease progression. The current research in Dr.